{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:58:21Z","timestamp":1706018301163},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.atherosclerosis.2007.10.021","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:36:33Z","timestamp":1196958993000},"page":"445-450","source":"Crossref","is-referenced-by-count":7,"title":["Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study"],"prefix":"10.1016","volume":"199","author":[{"given":"Erkki","family":"Ilveskoski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena E.","family":"Viiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Mikkelsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"P\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terho","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka J.","family":"Karhunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00041552-200501000-00005","article-title":"Neuropeptide Y as a far-reaching neuromediator: from energy balance and cardiovascular regulation to central integration of weight and bone mass control mechanisms. Implications for human diseases","volume":"14","author":"Zoccali","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.102.9.987","article-title":"Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease","volume":"102","author":"Gullestad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(89)90228-3","article-title":"Elevation of plasma neuropeptide Y levels in congestive heart failure","volume":"86","author":"Maisel","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0165-1838(98)00032-0","article-title":"Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation","volume":"70","author":"Gullestad","year":"1998","journal-title":"J Auton Nerv Syst"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib5","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1097\/01.ASN.0000089026.28617.33","article-title":"Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease","volume":"14","author":"Zoccali","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1748-1716.1990.tb08878.x","article-title":"Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit","volume":"138","author":"Gustafsson","year":"1990","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3940(93)90337-K","article-title":"Y stimulates DNA synthesis in vascular smooth muscle cells","volume":"149","author":"Shigeri","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004647-200101000-00010","article-title":"Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries","volume":"21","author":"You","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib9","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/4027","article-title":"Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels","volume":"4","author":"Karvonen","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0021-9150(01)00468-3","article-title":"Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men","volume":"159","author":"Karvonen","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.regpep.2004.10.011","article-title":"Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function","volume":"127","author":"Ding","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.ijo.0803314","article-title":"Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults","volume":"30","author":"van Rossum","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/sj.ejcn.1602621","article-title":"Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects","volume":"61","author":"Ukkola","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.hjh.0000125415.50839.7b","article-title":"Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population","volume":"22","author":"Wallerstedt","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0021-9150(03)00017-0","article-title":"Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y","volume":"167","author":"J\u00e4rvisalo","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1161\/01.CIR.100.6.608","article-title":"Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study","volume":"100","author":"Ilveskoski","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib17","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/hc3301.094907","article-title":"Platelet glycoprotein Ibalpha HPA-2 Met\/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death","volume":"104","author":"Mikkelsson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0021-9150(00)00683-3","article-title":"The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis","volume":"154","author":"Mikkelsson","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1050-1738(02)00232-3","article-title":"Neuropeptide Y: a novel mechanism for ischemic angiogenesis","volume":"13","author":"Zukowska","year":"2003","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1096\/fj.00-0436fje","article-title":"Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans","volume":"15","author":"Kallio","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib21","first-page":"1301","article-title":"Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples","volume":"145","author":"Isola","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2007.10.021_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0361-9230(93)90107-M","article-title":"Transient cerebral vasodilatory effect of neuropeptide Y mediated by nitric oxide","volume":"31","author":"Kobari","year":"1993","journal-title":"Brain Res Bull"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007006776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007006776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T16:58:37Z","timestamp":1557075517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007006776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0021915007006776"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.10.021","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}